# Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia

> **NCT00493545** · PHASE1 · UNKNOWN · sponsor: **Nventa Biopharmaceuticals Corporation** · enrollment: 24 (estimated)

## Conditions studied

- Cervical Intraepithelial Neoplasia

## Interventions

- **BIOLOGICAL:** HspE7 and Poly-ICLC

## Key facts

- **NCT ID:** NCT00493545
- **Lead sponsor:** Nventa Biopharmaceuticals Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-05
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2008-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00493545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00493545, "Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00493545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*